Followers | 744 |
Posts | 15751 |
Boards Moderated | 0 |
Alias Born | 12/23/2010 |
Tuesday, May 05, 2015 2:42:09 PM
Its a new Biotech ETF that was set up last year. They only invest in two groups of Biotech stocks: ones that are still in Clinical Trials - which as we all know takes years.....and the other group are those companies that have biotech approved products:
http://bioshares.com
...i just went to my charts, choose randomly tickers from each side (after of course hitting each tab to see the tickers) and on the side of Clinical Trials i found Market Caps many still over $500 million to over a Billion. On the 'approved and selling' side i found ones w Market Caps most all over a Billion.
The incredible thing here with ADMD, is that the initial Clinical Trials from the '80's and '90's are over for their Y-90 therapies -- we are just waiting on FDA to be Cleared for what category they should be classified under when hits medical market.
ADMD's Market Cap now is under $10 million.......and we arent waiting on some FDA approved bandages, side treatments, lotions etc...we are waiting on cancer killing new Modern day radioactive isotope Y-90 novel therapies: upon approval they will have a more exciting and modern/revolutionary biotech product then some Nasdaq biotechs(!!) .....let alone huge advantage over all those Naz biotechs still in Clinical Trials w no product.....yet their Market Caps are again in the hundreds of million of dollars.
Man, the opportunity here is immense in long run. Cause yes everyone will profit take on way up with approval, but in time ADMD should attract big biotech Naz money in the following months, to bring its Market Cap up to at least $100 mil ....which would be still waaaay less then Naz biotechs with cancer killing new and modern products on the market.
Recent RDGL News
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 07/17/2024 04:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 07/15/2024 10:02:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM